A closer look at geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD)

Geographic atrophy (GA) refers to an advanced form of age-related macular degeneration (AMD), which is a leading cause of vision loss worldwide.1,2 If you or someone you care about is affected by AMD, in particular GA, then this site is designed to provide you with more information and support.

This site is for information purposes only; it should not be used for diagnosing or treating a health problem or disease. Please consult your healthcare provider for further advice.

We will continue to add new content to this site over time. Make sure to visit us regularly for new information and resources.

Patient organisations supporting dryAMD.eu

This platform has been developed in collaboration with the following patient organisations to ensure that it truly meets the needs of people with AMD, as well as those who care for them. We would like to thank them for their invaluable input and continued support. Please click on the links below to visit the patient organisation websites.

The Swedish Retina Pigmentosa Association is a non-governmental association, based on voluntary resources, for and by people with retinitis pigmentosa (RP) and related hereditary degenerative retinal diseases.

Svenska RP-föreningen website

Are you living with geographic atrophy?

Take a look at our patient booklet for more information on geographic atrophy, including how to monitor, manage and live well.

Explore our resources

Visit the Resources section to gain access to useful resources, including an Amsler grid to monitor your vision at home, and a doctor discussion guide to help you prepare for appointments with your ophthalmologist or optometrist.


  1. Gehrs KM, et al. Ann Med. 2006;38(7):450–471.
  2. Fleckenstein M, et al. Ophthalmology. 2018;125(3):369–390.
  3. BrightFocus Foundation. Age-related macular degeneration: facts & figures. 2022. Available at: https://www.brightfocus.org/macular/article/age-related-macular-facts-figures (accessed May 2023).
  4. Sivaprasad S, et al. Ophthalmol Ther. 2019;8(1):115–124.

EU-GA-2300004     June 2023